PMC:7307149 / 10739-11199 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T67","span":{"begin":195,"end":198},"obj":"Body_part"},{"id":"T68","span":{"begin":327,"end":330},"obj":"Body_part"}],"attributes":[{"id":"A67","pred":"fma_id","subj":"T67","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A68","pred":"fma_id","subj":"T68","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"inity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T58","span":{"begin":40,"end":48},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"inity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T110","span":{"begin":51,"end":59},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T111","span":{"begin":72,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T112","span":{"begin":145,"end":150},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T113","span":{"begin":199,"end":200},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T114","span":{"begin":286,"end":293},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"inity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T57","span":{"begin":51,"end":59},"obj":"Chemical"},{"id":"T58","span":{"begin":286,"end":293},"obj":"Chemical"}],"attributes":[{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A58","pred":"chebi_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"inity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS"}

{"project":"LitCovid-PubTator","denotations":[{"id":"224","span":{"begin":195,"end":200},"obj":"Gene"},{"id":"227","span":{"begin":40,"end":50},"obj":"Species"},{"id":"228","span":{"begin":145,"end":150},"obj":"Species"},{"id":"229","span":{"begin":151,"end":164},"obj":"Species"}],"attributes":[{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"Gene:3106"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"Tax:2697049"},{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"Tax:9606"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"inity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS"}

{"project":"LitCovid-sentences","denotations":[{"id":"T65","span":{"begin":166,"end":231},"obj":"Sentence"},{"id":"T66","span":{"begin":232,"end":376},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"inity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS"}